Type 2 diabetes and frequency of prevention and control measures;Diabetes mellitus tipo 2 y frecuencia de acciones para su prevención y control

Salud Publica de Mexico

Volumn 55, Issue SUPPL.2, 2013, Pages 137-143

  Jiménez Corona, Aída ^a   Aguilar Salinas, Carlos A ^b   Rojas Martínez, Rosalba ^a   Hernández Ávila, Mauricio ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Mexico; Primary prevention; Quality of health care; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMAN; MALE; MEXICO; MIDDLE AGED; PREVALENCE; PRIMARY PREVENTION; YOUNG ADULT;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; PREVALENCE; PRIMARY PREVENTION; YOUNG ADULT;

EID: 84881503207     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.21149/spm.v55s2.5109     Document Type: Article

References (13)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995- 2025: prevalence numerical estimates, and projections. Diabetes Care 1998;21:1414-1431.
2. Barcelo A, Aedo C, Rajpathak S, Robles S. The Cost of Diabetes in Latin America and the Caribbean. Bull World Health Organ 2003;81:19-27.
3. Arredondo A. Diabetes: A Global Challenge with High Economic Burden for Public Health Systems and Society. doi:10.2105/ AJPH.2012.301106).
4. Guzmán JR, Lyra R, Aguilar-Salinas CA, Cavalcanti S, Escaño F, Tambasia M, et al. Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries. Latin American Diabetes Association. Rev Panam Salud Publica 2010;28:463-471.
5. American Diabetes Association. Standard of Medical Care in Diabetes- 2012. Diabetes Care 2012; 35:s1-s63.
6. Harris SB, Ekoé JM, Zdanowicz Y, Webster-Bogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res Clin Pract 2005;70:90-97.
7. Toumilehto J, Schwarz P, Lindström J. Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts. Diabetes Care 2011; 34:s210-s214.
8. Renders CM, Valk GD, Franse LV, Schellevis FG, van Eijk JT, van der Wal G. Long-term effectiveness of a quality improvement program for patients with type 2 diabetes in general practice. Diabetes Care 2001; 24:1365-1370.
9. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The longterm effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20 year follow-up study. Lancet 2008; 371:1783-1789.
10. Knowler W, Barret-Connor E, Fowler SE, Hamman RF, Lachin JM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:396-403.
11. Lee PG, Cigolle C, Blaum C. The co-occurrence of chronic diseases and geriatric syndromes: the health and retirement study. J Am Geriatr Soc 2009; 57: 511-516.
12. Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med 2009; 151: 854-860.
13. Gómez-Pérez FJ, Rojas R, Villalpando S, Barquera S, Rull J, Aguilar- Salinas CA. Prevention of cardiovascular disease based on lipid lowering treatment: a challenge for the Mexican health system. Salud Publica Mex 2010;52:s54-s56.